Page last updated: 2024-09-03

l 663581 and devazepide

l 663581 has been researched along with devazepide in 1 studies

Compound Research Comparison

Studies
(l 663581)
Trials
(l 663581)
Recent Studies (post-2010)
(l 663581)
Studies
(devazepide)
Trials
(devazepide)
Recent Studies (post-2010) (devazepide)
1200780542

Protein Interaction Comparison

ProteinTaxonomyl 663581 (IC50)devazepide (IC50)
Bile salt export pumpHomo sapiens (human)10
Cholecystokinin receptor type ARattus norvegicus (Norway rat)0.0009
Gastrin/cholecystokinin type B receptorRattus norvegicus (Norway rat)0.0008
Cholecystokinin receptor type AHomo sapiens (human)0.0002
Gastrin/cholecystokinin type B receptorHomo sapiens (human)0.245
Cholecystokinin receptor type ACavia porcellus (domestic guinea pig)0.27

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, JH; Lin, TH1

Other Studies

1 other study(ies) available for l 663581 and devazepide

ArticleYear
Effects of protein binding and experimental disease states on brain uptake of benzodiazepines in rats.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 253, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Blood-Brain Barrier; Brain; Devazepide; Diabetes Mellitus, Experimental; Diazepam; Kidney Diseases; Liver Diseases; Male; Phenylurea Compounds; Protein Binding; Rats; Rats, Inbred Strains; Serum Albumin

1990